Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons
- PMID: 17267760
- DOI: 10.1152/jn.00603.2006
Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons
Abstract
The cannabinoid receptor CB1 is found in abundance in brain neurons, whereas CB2 is essentially expressed outside the brain. In the neocortex, CB1 is observed predominantly on large cholecystokinin (CCK)-expressing interneurons. However, physiological evidence suggests that functional CB1 are present on other neocortical neuronal types. We investigated the expression of CB1 and CB2 in identified neurons of rat neocortical slices using single-cell RT-PCR. We found that 63% of somatostatin (SST)-expressing and 69% of vasoactive intestinal polypeptide (VIP)-expressing interneurons co-expressed CB1. As much as 49% of pyramidal neurons expressed CB1. In contrast, CB2 was observed in a small proportion of neocortical neurons. We performed whole cell recordings of pyramidal neurons to corroborate our molecular findings. Inhibitory postsynaptic currents (IPSCs) induced by a mixed muscarinic/nicotinic cholinergic agonist showed depolarization-induced suppression of inhibition and were decreased by the CB1 agonist WIN-55212-2 (WIN-2), suggesting that interneurons excited by cholinergic agonists (mainly SST and VIP neurons) possess CB1. IPSCs elicited by a nicotinic receptor agonist were also reduced in the presence of WIN-2, suggesting that neurons excited by nicotinic agonists (mainly VIP neurons) indeed possess CB1. WIN-2 largely decreased excitatory postsynaptic currents evoked by intracortical electrical stimulation, pointing at the presence of CB1 on glutamatergic pyramidal neurons. All WIN-2 effects were strongly reduced by the CB1 antagonist AM 251. We conclude that CB1 is expressed in various neocortical neuronal populations, including glutamatergic neurons. Our combined molecular and physiological data suggest that CB1 widely mediates endocannabinoid effects on glutamatergic and GABAergic transmission to modulate cortical networks.
Similar articles
-
Extensive overlap of mu-opioid and nicotinic sensitivity in cortical interneurons.Cereb Cortex. 2007 Aug;17(8):1948-57. doi: 10.1093/cercor/bhl104. Epub 2006 Oct 26. Cereb Cortex. 2007. PMID: 17068095
-
Local disinhibition of neocortical neuronal circuits causes augmentation of glutamatergic and GABAergic synaptic transmission in the rat neostriatum in vitro.Exp Neurol. 1999 May;157(1):180-93. doi: 10.1006/exnr.1999.7039. Exp Neurol. 1999. PMID: 10222121
-
5-HT3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons.J Neurosci. 2002 Sep 1;22(17):7389-97. doi: 10.1523/JNEUROSCI.22-17-07389.2002. J Neurosci. 2002. PMID: 12196560 Free PMC article.
-
Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.Ann N Y Acad Sci. 2006 Aug;1074:514-36. doi: 10.1196/annals.1369.052. Ann N Y Acad Sci. 2006. PMID: 17105950 Review.
-
Dendritic release of retrograde messengers controls synaptic transmission in local neocortical networks.Neuroscientist. 2005 Aug;11(4):334-44. doi: 10.1177/1073858405275827. Neuroscientist. 2005. PMID: 16061520 Review.
Cited by
-
Tsc1 Loss in VIP-Lineage Cortical Interneurons Results in More VIP+ Interneurons and Enhanced Excitability.Cells. 2023 Dec 26;13(1):52. doi: 10.3390/cells13010052. Cells. 2023. PMID: 38201256 Free PMC article.
-
Molecular and functional characterization of GAD67-expressing, newborn granule cells in mouse dentate gyrus.Front Neural Circuits. 2013 Apr 2;7:60. doi: 10.3389/fncir.2013.00060. eCollection 2013. Front Neural Circuits. 2013. PMID: 23565079 Free PMC article.
-
Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation.J Neurosci. 2011 Oct 26;31(43):15560-8. doi: 10.1523/JNEUROSCI.2970-11.2011. J Neurosci. 2011. PMID: 22031901 Free PMC article.
-
Endocannabinoid signaling and synaptic function.Neuron. 2012 Oct 4;76(1):70-81. doi: 10.1016/j.neuron.2012.09.020. Neuron. 2012. PMID: 23040807 Free PMC article. Review.
-
Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortex.Neuropsychopharmacology. 2012 Apr;37(5):1104-14. doi: 10.1038/npp.2011.262. Epub 2011 Nov 2. Neuropsychopharmacology. 2012. PMID: 22048459 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
